Biopharmaceutical company that is developing botanical drugs for the treatment of addictions
NFL BIOSCIENCES has raised €3.0M across 1 funding round from 2 investors, most recently a round in Jan 2023. Based in France; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-01-31 | Other | €3.0M |
| Angel Investors,Private Investors |
| View deal → |
